Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

13:21 EST 29th January 2015 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,600+

Tuesday 27th January 2015

Celgene Corporation to Webcast at Upcoming Investor Conferences

Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com. Wednesday, February 11, 2015, Celgene will present at the Leer...

PreAnalytiX GmbH, NuGEN Technologies and RUCDR Infinite Biologics Partner to Develop Clinically Validated RNA-Seq Workflow for Whole Blood Samples

PreAnalytiX GmbH, NuGEN Technologies, Inc. and RUCDR Infinite Biologics (RUCDR), today announced a joint project to validate an end-to-end workflow for the reproducible collection and processing of whole blood for RNA sequencing (RNA-Seq) in clinical studies. The multi-site validation study involves three independent laboratories processing samples collect...

Euclises Announces Appointment of Bobby Sandage as New CEO

Development Experience to Drive Entry of Novel COX-2 Inhibitors into Clinical Trials for Cancer Euclises Pharmaceuticals, Inc., a biotechnology company developing novel cyclooxygenase-2 (COX-2) inhibitors for the treatment of cancer, today announced that Bobby W. Sandage, Jr., Ph.D., has joined the company as its President and CEO. He replaces Rajesh D...

PsychoGenics Achieves Another Milestone in Drug Discovery Collaboration with Sunovion

PGI Drug Discovery LLC (PsychoGenics), today announced the achievement of a milestone in its drug discovery and development collaboration with Sunovion Pharmaceuticals Inc. In August 2007, PsychoGenics and Sunovion entered into a drug discovery and development agreement to combine their complementary strengths and expertise to identify a new gener...

Incyte to Report Fourth Quarter/Year-End 2014 Financial Results on February 12

Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, February 12, 2015. The schedule for the press release and conference call is as follows:       ...

Research into brain control of liver lipid production could cause break in obesity, diabetes treatment

Ways of keeping the heart healthy has widened, with the discovery that the brain can help fight off hardening of the arteries.

Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017

LONDON, Jan. 27, 2015 /PRNewswire/ -- EXECUTIVE SUMMARYStem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Categorized by stage of life, several broad categories of stem cells exist, including:- Embryonic stem cells, derived from blastocysts- Post-natal stem cells, derived from newb...

Global Cell-Based Assays Market

LONDON, Jan. 27, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Cell-Based Assays in US$ Million by the following Applications: Basic Research, ADME Testing, and Drug Discovery. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year histo...

Brain region vulnerable to aging is larger in those with longevity gene variant

People who carry a variant of a gene that is associated with longevity also have larger volumes in a front part of the brain involved in planning and decision-making, according to researchers at UC San Francisco.

The BBVA Foundation Frontiers of Knowledge Award in Biomedicine goes to Tony Hunter, Joseph Schlessinger and Charles Sawyers for opening the door to the personalized treatment of cancer

MADRID, Jan. 27, 2015 /PRNewswire/ -- The BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category is shared in this seventh edition by Tony Hunter, professor and Director of the Salk Institute Cancer Center in La Jolla, California; Joseph Schlessinger, Chairman of the Department of Pharmacology at Yale University School of Medicine, New Haven, and Charles Sawyers, Human Oncol...

Forbion Capital Partners leads CAD 13.5 Million (EUR 9.6 million) Series B financing round for enGene Inc.

Naarden, The Netherlands, January 26, 2015 - Forbion Capital Partners, a Dutch life-sciences venture capital firm, announces today that it has led the closing of a CAD 13.5 million (EUR 9.6 million) series B financing round for enGene, Inc. with a syndicate of leading life-science investors. Sander van Deventer from Forbion Capital Partners has joined the enGene Board of Directors. Other membe...

EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors

Non-small-cell lung cancer is the leading cause of cancer-related death worldwide. Chemotherapies such as the topoisomerase II (TopoII) inhibitor etoposide effectively reduce disease in a minority of patients with this cancer; therefore, alternative ...

Transplantation: Biomarkers in transplantation—the devil is in the detail

Numerous studies have suggested the utility of non-invasive molecular biomarkers to monitor recipients of kidney transplants. A new correlation-based algorithm using stepwise analysis of gene expression data from peripheral blood samples, claiming to...

New Rare Earth Element Discovered in Peru

Peruvian minerals group RioSol has staked a claim to what it says is a "significant" rare earth element and poly-metallic discovery in the 10-kilometer Capacscaya and adjacent claims. The area 123 kilometers northwest of Cusco, Peru, is believed to h...

New Sampling Technology Allows Reaction Monitoring Under Any Chemical Conditions

METTLER TOLEDO ReactIR technology allows the sampling of any chemistry under a wide range of batch and continuous reaction conditions. Robust sampling technology enables chemical reaction monitoring and analysis of even the most difficult chemistry including corrosive slurries, acidic slurries, caustic slurries and abrasive slurries. (PRWEB) January 27, 2015 METTLER TOLEDO is pleased to announce...

Vaccinex announces groundbreaking preclinical data demonstrating an immunomodulatory role for anti-SEMA4D antibody blockade in colon and breast cancer

ROCHESTER, N.Y., Jan. 27, 2015 /PRNewswire/ -- Vaccinex Inc., a clinical-stage biotechnology company engaged in the discovery and development of therapeutic monoclonal antibodies to treat cancer and neurodegenerative diseases, today announced publication of a manuscript entitled "Antibody blockade of semaphorin 4D promotes immune infiltration into tumor and enhances response to other immunomodulat...

American Heart Association continues global expansion of lifesaving work

DALLAS, Jan. 27, 2015 /PRNewswire/ -- Cardiovascular disease knows no borders, and currently accounts for more than 17 million deaths per year, a figure expected to reach approximately 23 million per year by 2030. That's why the American Heart Association (AHA) is committed to building healthier lives, free of cardiovascular diseases and stroke around the world through a continued expansion o...

New England Biolabs® releases Rapid PNGase F for biotherapeutic development and production

IPSWICH, Mass., Jan. 27, 2015 /PRNewswire/ -- New England Biolabs (NEB®) today announced the release of its new Rapid PNGase F glycosidase at the 2015 WCBP Meeting in Washington, DC.  This broad-specificity glycosidase completely removes N-glycans from antibodies and fusion proteins in 10 minutes or less. This important technical advancement offers the potential to accelerate the qu...

Tecan introduces Fluent™ Laboratory Automation Solution for compound management

Tecan will soon be launching a new Fluent™ Laboratory Automation Solution designed to offer greater throughput and flexibility for compound management workflows*. Building on the success of the Fluent™ cell-based assay workstation launched in summer 2014, this second application-oriented system introduces a number of new hardware and software options th

Intracranial stimulation proved efficient in the recovery of learning and memory in rats

Stimulation of the hypothalamus completely reverses learning and memory deficits caused by brain lesions in rats, according to a first time discovery by a group of researchers led by the UAB. The research has also served to study the mechanisms throu...

Taxus Cardium Announces Scientific Presentation And Clinical Update On Phase 3 Angiogenic Gene Therapy At The 2015 Phacilitate 11th Annual Cell & Gene Therapy Forum

SAN DIEGO, Jan. 27, 2015 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group (Symbol: CRXM) today announced a presentation at the 2015 Phacilitate Annual Cell & Gene Therapy Forum in Washington, DC. The review and clinical update, entitled "Progress in Angiogenic Gene Therapy for Coronary Artery Disease" was presented by the Company's Chief Scientific Officer, Gabor M. Rubanyi, M.D., Ph.D...

Genetic Disorders UK and Global Genes™ Collaborate on the First Event for Leaders of Rare Genetic Disorder Charities and Support Groups

Global Genes, a leading rare disease patient advocacy organization based in the USA, has partnered with Genetic Disorders UK (GDUK), the UK charity famous for its national fundraising campaign, Jeans for Genes Day, to deliver t

Naurex's First Orally Active Molecule, NRX-1074, Demonstrates Statistically Significant Improvement in Depression Scores within 24 Hours in Phase 2 Study for Major Depressive Disorder

EVANSTON, Ill., Jan. 27, 2015 /PRNewswire/ -- Naurex Inc., a biopharmaceutical company leveraging its unique platform to develop novel drugs for diseases of the central nervous system (CNS), today announced that a single intravenous dose of NRX-1074 resulted in a statistically significant improvement in depression scores within 24 hours in a Phase 2 single-dose study in subjects with major depress...

Oral Cancer Is On The Rise, Are You At Risk?

PALM SPRINGS, Calif., Jan. 27, 2015 /PRNewswire-USNewswire/ -- While most other cancers are declining, oral cancer continues to rise, affecting over 43,000 Americans in 2014 alone. Due to late stage discovery, oral cancer kills one American every hour. Increased awareness and more advanced screening technologies enable early detection of oral cancer, thus increasing survival rate of those dia...

Bio-Techne To Host Conference Call On February 3, 2015 To Announce Second Quarter Financial Results

MINNEAPOLIS, Jan. 27, 2015 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, February 3, 2015, at 8:00 a.m. CST to review second quarter fiscal 2015 financial results. Access to the discussion may be obtained as follows: Time: 8:00 a.m. CST Date: February 3, 2015 Dial-in:


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks